Germline Single-Nucleotide Polymorphism GFI1-36N Causes Alterations in Mitochondrial Metabolism and Leads to Increased ROS-Mediated DNA Damage in a Murine Model of Human Acute Myeloid Leukemia.

Saved in:
Bibliographic Details
Title: Germline Single-Nucleotide Polymorphism GFI1-36N Causes Alterations in Mitochondrial Metabolism and Leads to Increased ROS-Mediated DNA Damage in a Murine Model of Human Acute Myeloid Leukemia.
Authors: Vorwerk J; Department of Hematology and Oncology, University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, 23562 Lübeck, Germany.; Department of Hematology, Hemostaseology, Oncology, and Pneumology, West German Cancer Center Essen-Münster (WTZ), University Hospital Münster, 49149 Münster, Germany., Liu L; Department of Hematology, Hemostaseology, Oncology, and Pneumology, West German Cancer Center Essen-Münster (WTZ), University Hospital Münster, 49149 Münster, Germany.; Department of Hematology, First Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, China., Stadler TH; Department of Hematology and Oncology, University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, 23562 Lübeck, Germany., Frank D; Department of Hematology, Hemostaseology, Oncology, and Pneumology, West German Cancer Center Essen-Münster (WTZ), University Hospital Münster, 49149 Münster, Germany., Ahmed HMM; Department of Hematology and Oncology, University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, 23562 Lübeck, Germany.; Department of Hematology, Hemostaseology, Oncology, and Pneumology, West German Cancer Center Essen-Münster (WTZ), University Hospital Münster, 49149 Münster, Germany., Patnana PK; Department of Hematology and Oncology, University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, 23562 Lübeck, Germany.; Department of Hematology, Hemostaseology, Oncology, and Pneumology, West German Cancer Center Essen-Münster (WTZ), University Hospital Münster, 49149 Münster, Germany., Kebenko M; Department of Hematology and Oncology, University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, 23562 Lübeck, Germany., Dazert E; Department of Hematology and Oncology, University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, 23562 Lübeck, Germany., Opalka B; Department of Hematology and Stem Cell Transplantation, West German Cancer Center Essen-Münster (WTZ), University Hospital Essen, 45147 Essen, Germany., von Bubnoff N; Department of Hematology and Oncology, University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, 23562 Lübeck, Germany., Khandanpour C; Department of Hematology and Oncology, University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, 23562 Lübeck, Germany.; Department of Hematology, Hemostaseology, Oncology, and Pneumology, West German Cancer Center Essen-Münster (WTZ), University Hospital Münster, 49149 Münster, Germany.
Source: Biomedicines [Biomedicines] 2025 Jan 05; Vol. 13 (1). Date of Electronic Publication: 2025 Jan 05.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first